27 studies found for:    integrin αvβ3
Show Display Options
Rank Status Study
1 Completed Receptivity Assessment of Homogeneous Endometrium in Late Follicle Phase
Condition: Infertile
Intervention:
2 Recruiting 99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients
Condition: Lung Cancer
Intervention: Drug: 99mTc-3PRGD2
3 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma
Condition: Glioma
Intervention: Drug: 68Ga-BNOTA-PRGD2
4 Recruiting A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Condition: Glioblastoma
Interventions: Other: Chemoradiation Therapy;   Other: Adjuvant Therapy
5 Completed A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
Conditions: High-grade Glioma;   Lung Cancer;   Head & Neck Cancer;   Sarcoma;   Melanoma
Intervention: Drug: [18F]AH-111585
6 Not yet recruiting RGD-PET-CT in Cancer Angiogenesis
Condition: Carcinoma, Renal Cell
Intervention: Drug: 18F-RGD-PET-CT and perfusion CT scans on 3 occasions
7 Recruiting 18F FPPRGD2 Positron Emission Tomography/Computed Tomography in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Brain Tumor;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Hypopharyngeal Cancer;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Laryngeal Cancer;   Recurrent Lip and Oral Cavity Cancer;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Nasopharyngeal Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Oropharyngeal Cancer;   Recurrent Pancreatic Cancer;   Recurrent Paranasal Sinus and Nasal Cavity Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVB Colon Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVC Salivary Gland Cancer;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Radiation: fludeoxyglucose F 18;   Radiation: 2-fluoropropionyl-labeled pegylated dimeric RGD peptide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
8 Recruiting [18F]Fluciclatide PET Imaging of Pazopanib Response
Condition: Kidney Neoplasm
Intervention: Drug: 18F-Fluciclatide
9 Not yet recruiting Angiogenesis and Fibrosis in Myocardial Infarction
Conditions: Myocardial Infarction;   Fibrosis;   Neovascularization, Pathologic
Interventions: Procedure: Cardiac MRI scan;   Radiation: CT-PET scan;   Radiation: CT-coronary angiogram
10 Withdrawn Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: leuprolide acetate;   Drug: squalamine lactate;   Procedure: adjuvant therapy;   Procedure: antiandrogen therapy;   Procedure: antiangiogenesis therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Procedure: releasing hormone agonist therapy
11 Not yet recruiting Angiogenesis and Fibrosis in Aortic Stenosis
Conditions: Aortic Stenosis;   Fibrosis;   Neovascularization, Pathologic
Interventions: Procedure: Cardiac MRI scan;   Radiation: CT-PET scan;   Procedure: Echocardiogram;   Radiation: CT-coronary angiogram scan;   Procedure: Aortic Valve Replacement
12 Recruiting Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer
Condition: Metastatic Malignant Neoplasm
Intervention: Drug: Plasmid AMEP
13 Unknown  Efferocytosis and Genomic Polymorphism in Autoimmune Diseases
Conditions: SLE;   Rheumatoid Arthritis;   Healthy Subjects
Intervention:
14 Completed Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Biological: MEDI-522;   Other: Placebo
15 Completed Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
Conditions: Melanoma;   Malignant Metastatic Melanoma
Interventions: Biological: MEDI--522;   Biological: Integrin + Dacarbazine
16 Completed Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
Condition: Cancer
Intervention: Drug: MEDI-522
17 Terminated
Has Results
Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer
Conditions: Recurrent Renal Cell Cancer;   Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Drug: etaracizumab;   Biological: bevacizumab
18 Completed Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
Conditions: Endometriosis;   Infertility
Interventions: Drug: Leuprolide acetate in depot suspension;   Drug: Leuprolide acetate;   Drug: leuprolide acetate
19 Completed MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: MEDI-522;   Biological: Docetaxel + Prednisone* + Zoledronic Acid
20 Completed Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Biological: etaracizumab

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years